Stay updated on Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.

Latest updates to the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedFooter revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedPage revision tag updated from v3.4.3 to v3.5.0; the new Revision: v3.5.0 appears and the old Revision: v3.4.3 tag is removed.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. No visible changes to study details or page layout.SummaryDifference0.0%

- Check74 days agoChange DetectedAdded Revision: v3.4.2. Removed the lapse-in-government-funding notice and Revision: v3.4.1.SummaryDifference0.3%

- Check81 days agoChange DetectedNotice added about a lapse in government funding with information to check cc.nih.gov and opm.gov; page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check88 days agoChange DetectedThe page now adds a 'Show glossary' option and updates footer metadata to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', along with a 'No FEAR Act Data' notice. These are non-critical UI and metadata updates that do not affect core study content.SummaryDifference0.2%

Stay in the know with updates to Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.